Crowdonomics
All companies
GAMEDAY CBD BY AMERICAN LABS logo

GAMEDAY CBD BY AMERICAN LABS

Operating

American Labs

Healthcare · Founded 2021

Visit website

Wellness brand to provide athletes and active lifestyle consumers natural, effective muscle and joint relief

Post-money valuation ⓘ
$3.0M
As of Feb 2025 · from Gameday CBD by American Labs Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$0
Across 1 round since 2024
Latest share price
$1.73
Gameday CBD by American Labs Preferred Stock 1 offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$10K
−$201K
2022
$18K
−$222K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$10,328
$17,604
Cost of goods sold
$25,344
$10,761
Gross margin
-145%
39%
Net income
-$200,975
-$222,264
Taxes paid
$0
$0
Balance sheet
Cash
$25,595
$7,629
Accounts receivable
$452
$3,467
Total assets
$61,699
$43,634
Short-term debt
$0
$0
Long-term debt
$50,160
$196,389
Total liabilities
$50,160
$196,389
Other
Headcount
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$3.0M
post-money
Gameday CBD by American Labs Preferred Stock 1

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Gameday CBD by American Labs Preferred Stock 1ClosedReg CF · Preferred Equity · via StartEngine
Raised $0 / $124KPost-money $3M

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UFeb 24, 20250001665160-25-000296
    EDGAR
  • Form CNov 18, 20240001665160-24-001644
    EDGAR
Source: ManualCIK 0002045289Share price $1.73

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.